You are here

Simon Johnson
By Simon Johnson - Oct 04,2021
WASHINGTON, DC — A major debate is in the making, or, more accurately, beginning to be reopened, in the United States about the appropriate objectives and triggers for monetary policy in the modern American economy.
By Simon Johnson - Sep 04,2021
WASHINGTON, DC — Throughout 2020 and into early 2021, there was hope that with some luck and enough vaccines, it would be possible to end the COVID-19 pandemic in a quick and decisive manner. By this summer, it became clear that this would not happen in the United States.
By Simon Johnson - Jul 05,2021
WASHINGTON, DC — If a meteor hits Earth, a major natural disaster strikes, or any other shock of previously unanticipated dimensions occurs, how should economic policymakers respond?
By Simon Johnson - May 31,2021
WASHINGTON, DC — In March and April 2020, when COVID-19 first struck the United States, the virus that causes it, SARS-CoV-2, swept through US nursing homes.
By Simon Johnson - Apr 11,2021
WASHINGTON, DC — In the immediate aftermath of the 2008 global financial crisis, measures were taken to prevent another potential systemic meltdown.
By Simon Johnson - Mar 08,2021
WASHINGTON, DC  —  In “The Great Realisation”, a compelling four-minute video, the poet Tomos Roberts (aka Tom Foolery) suggests a potential silver lining to the COVID-19 cataclysm.
By Simon Johnson - Nov 04,2020
WASHINGON, DC — The US COVID-19 crisis fits the pattern of President Donald Trump’s career with its serial bankruptcies.
By Simon Johnson - Oct 01,2020
 WASHINGTON, DC – There is a growing consensus that one or more COVID-19 vaccines will become available at some point in early 2021. Within a year, many people in the United States, and some other countries, will be vaccinated.
By Simon Johnson - Sep 01,2020
WASHINGTON, DC — To escape the clutches of a pandemic, a country needs three things. First and foremost, it needs a sufficient understanding of the disease, including how transmission occurs.
By Simon Johnson - Aug 23,2020
WASHINGTON, DC — To track the presence of SARS-CoV-2, the virus that causes COVID-19, the United States is relying heavily on polymerase chain reaction (PCR) live virus testing at massive scale.



Get top stories and blog posts emailed to you each day.